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A B S T R A C T
The human brain consumes 20% of the total basal oxygen (O2) budget to support ATP intensive neuronal ac-
tivity. Without sufficient O2 to support ATP demands, neuronal activity fails, such that, even transient ischemia
is neurodegenerative. While the essentiality of O2 to brain function is clear, how oxidative stress causes neu-
rodegeneration is ambiguous. Ambiguity exists because many of the reasons why the brain is susceptible to
oxidative stress remain obscure. Many are erroneously understood as the deleterious result of adventitious O2
derived free radical and non-radical species generation. To understand how many reasons underpin oxidative
stress, one must first re-cast free radical and non-radical species in a positive light because their deliberate
generation enables the brain to achieve critical functions (e.g. synaptic plasticity) through redox signalling (i.e.
positive functionality). Using free radicals and non-radical derivatives to signal sensitises the brain to oxidative
stress when redox signalling goes awry (i.e. negative functionality). To advance mechanistic understanding, we
rationalise 13 reasons why the brain is susceptible to oxidative stress. Key reasons include inter alia unsaturated
lipid enrichment, mitochondria, calcium, glutamate, modest antioxidant defence, redox active transition metals
and neurotransmitter auto-oxidation. We review RNA oxidation as an underappreciated cause of oxidative stress.
The complex interplay between each reason dictates neuronal susceptibility to oxidative stress in a dynamic
context and neural identity dependent manner. Our discourse sets the stage for investigators to interrogate the
biochemical basis of oxidative stress in the brain in health and disease.
1. The brain and oxygen: locked in a lethal dance to the death
Despite weighing a mere ~1400 g the human brain voraciously
consumes ~20% of the total basal oxygen (O2) budget to power its ~86
billion neurons and their unfathomably complex connectome spanning
trillions of synapses [1–3]—abetted by ~250–300 billion glia [4,5].
The brain must “breathe” to think—even transient ischemia heralds
mass neurodegeneration [6]. Depriving the brain of O2 for just 30min
in ischemic stroke exacts a devastating toll: every minute ~1.9 million
neurons and ~14 million synapses perish [6]. Neurons and their sy-
napses perish because without sufficient O2, mitochondria are unable to
reduce O2 to H2O to support ATP synthesis [7]. Yet, perversely, at least
prima facia, the brain carefully regulates O2 use. For the simple bio-
chemical reason that ground state molecular O2 is a di-radical and,
therefore, a potentially toxic mutagenic gas. Fortuitously, the potential
oxidising power of O2 is constrained by a chemical quirk: because the
two lone electrons spin in parallel O2 can only accept one electron at a
time [8,9].
If spin restriction limits its reactivity, why is O2 considered toxic?
The answer lies in its ability to give rise to free radical and non-radicals,
notably superoxide anion (O2.-), hydrogen peroxide (H2O2) and hy-
droxyl (.OH) (their biochemistry is reviewed in [8,10,11]). Such species
are usually considered to constitute the “dark side” of O2 biochemis-
try—the unavoidable cost of using O2 to respire [12]. It has long been
assumed that their adventitious and unwanted generation sensitises the
brain to “oxidative stress”. Indeed, oxidative stress is intimately tied to
neurodegeneration [13,14]. However, the simple dichotomy that O2 is
good and its reactive progeny (e.g. O2.-) are bad, fails to explain why
and how the brain is susceptible to oxidative stress because it is in-
correct. To understand why and how the brain is susceptible to oxida-
tive stress, one must abandon the dogma that O2 derived free radicals
and non-radicals are just deleterious metabolic by-products and con-
sider their nuances. For example, nestled within the brains sensitivity to
hypoxia, resides an extraordinary molecular detail: mitochondrial O2.-
signals beneficial adaptive responses [7]. Far from being an exception,
such redox signalling is pervasive [15,16]. Oxidative stress can arise
when redox signalling goes awry (i.e. the “Janus” face of redox sig-
nalling). Redox nuances mean the brains susceptibility to oxidative
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stress is seldom rationalised, which hinders attempts to disambiguate
the complex relationship between oxidative stress and neurodegenera-
tion. To advance mechanistic understanding, we biochemically ratio-
nalise 13 reasons why the brain is susceptible to oxidative stress. To do
so, we draw on the seminal work of Barry Halliwell and John Gutter-
idge [17–19].
1.1. Redox signalling: reactive species play useful biological roles
A singular and indeed often overlooked reason why the brain is
susceptible to oxidative stress is because reactive species play useful
biological roles [19,20]. Two exemplars serve to illustrate the point.
First, Chang's group [21] have shown that NADPH oxidase 2 (NOX2)
derived O2.- and H2O2 regulate adult hippocampal progenitor cell
growth via PI3K/Akt signalling. Their findings reveal a beneficial,
homeostatic role for NOX2 derived O2.-/H2O2 in the maintenance of
essential neural progenitors [21]. The expression of NOX2, a dedi-
cated O2.- producing enzyme [22,23], alone hints at an essential role
for redox signalling. A related corollary is that NOX isoforms regulate
hippocampal long term potentiation (LTP)—important for learning
and memory [24]. Deleting NOX2 causes cognitive impairment in
mice [25]. Second, Vriz's group, have identified beneficial roles for
NOX derived H2O2 in axonal pathfinding and regeneration [26,27].
Axonal pathfinding wires the developing brain [28], in part, via
secreted chemoattractant and chemo-repellent cues that ensure
correct target innervation. Pharmacologically inhibiting NOX2 medi-
ated O2.-/H2O2 generation retards retinal ganglion cell axon out-
growth in vivo in larval zebrafish, placing H2O2 as an endogenous
chemoattractant [26].
1.2. Calcium
Action potentials causes dramatic calcium (Ca2+) fluxes in pre-sy-
naptic terminals, raising [Ca2+] by ~four orders of magnitude (from
0.01 to ~100 µM [29]). Ca2+ transients trigger neurotransmitter ve-
sicle exocytosis [29]. Consequently, activity dependent Ca2+ transients
control bidirectional synaptic plasticity [30]. Bidirectional synaptic
plasticity is fundamental to brain function—being required for learning
and memory to give just one prominent example [31–33]. The brains
reliance on Ca2+ signalling [34] can cause oxidative stress: the nature
of which is variable and context dependent owing to the complex re-
lationship between Ca2+ and the intracellular redox environment [19].
The interested reader is referred elsewhere for a comprehensive review
of Ca2+/ redox interplay [35], our discourse is confined to three points.
First, Ca2+ transients stimulate neuronal nitric oxide synthase (nNOS)
mediated nitric oxide (NO.) synthesis [36], provided sufficient O2 and
NADPH are available for NO. synthesis [37]. Residually elevated in-
tracellular [Ca2+] may, therefore, increase NO., which can inhibit mi-
tochondrial respiration by binding to cytochrome c oxidase (COX) [38].
NO. reacts at a diffusion controlled rate with O2.- to yield peroxynitrite
(ONOO-) [39]. ONOO- can lead to carbonate (CO3.-) and nitrogen di-
oxide (NO2.-) radical generation secondary to reaction with carbon di-
oxide (CO2) to yield peroxomonocarbonate [40]. CO3.- and NO2.- may
contribute to neurodegeneration—for example, by nitrating heat shock
protein 90 to induce apoptosis in amyotrophic lateral sclerosis (ALS)
[41]. A related corollary: Ca2+ can increase phospholipase A2 activity
[34]. Phospholipase A2 isoforms de-esterify membrane phospholi-
pids—which can promote enzymatic (i.e. via LOX [42]) and non-en-
zymatic peroxidation of bis-allyic unsaturated lipids [43].
Second, intracellular Ca2+ release—important for synaptic plasti-
city [44]—is redox regulated [45,46]. For example, Hajnoczky’ group
[47] show that mitochondrial H2O2 nanodomains regulate Ca2+ tran-
sients. Ca2+ transients induce endoplasmic reticulum (ER) mitochon-
dria contacts, termed ER associated mitochondria membranes (MAM
[48,49]), leading to mitochondrial Ca2+ uptake. Mitochondrial Ca2+
uptake amplifies ER Ca2+ release by inducing potassium uptake to
thereby increase matrix volume and compress the MIS to concentrate
matrix H2O2 at the MAM [47]. These authors suggest H2O2 induces ER
Ca2+ release via the IP3 receptor, consistent with its redox regulation
via cysteine oxidation [50]. Because the MAM regulates a host of mi-
tochondrial functions (e.g. transport and biogenesis [48]) one can easily
envisage how dysregulated inter-organelle communication can cause
aberrant local Ca2+/H2O2 signalling associated oxidative stress [45].
To be sure, dysregulated MAM signalling is linked to neurodegeneration
in AD and ALS [51]. For example, Stoica et al. [52] show that mutant
TD43—a pathological trigger in ALS and frontotemporal dementia
[53]—reduces MAM contacts and thereby disrupts Ca2+ homeostasis.
(Figs. 1–6)
A third related point of interplay: mitochondrial Ca2+ overload
opens the mitochondrial permeability transition pore (mPTP) [54].
mPTP opening induces O2.-/H2O2 efflux and abolishes ATP synthesis
[55–57]. Transient mPTP opening enables mitochondria to re-set ma-
trix Ca2+ [54,58], and is, perhaps, permissive for redox signalling by
enabling O2.-/H2O2 to exit mitochondria to evade matrix metabolism
[59] (a phenomenon that may be linked to mitochondrial contractions
[60,61]). Prolonged mPTP opening heralds necroptosis [62]. In addi-
tion, Ca2+ overload can regulate intrinsic apoptosis. Importantly, ne-
croptosis and apoptosis are linked to neurodegeneration [63,64]. Be-
cause mitochondrial Ca2+ uptake supports ATP synthesis [65–67],
decreased mitochondrial [Ca2+] may cause oxidative stress by
Fig. 1. Molecular diagram of a ground state diatomic oxygen molecule (3∑g-O2). Left
and right sides depict the electronic configuration of constituent oxygen atoms while the
middle panel depicts bonding and antibonding orbitals within 3∑g-O2 by energy level.
3∑g
-O2 is a di-radical because lone (i.e. single) electrons occupy the two degenerate π*2p
antibonding orbitals (shown in red). The two lone electrons possess parallel spin-
s—locking 3∑g-O2 in a spin restricted state. Spin restriction is fortuitous because it con-
strains the reactivity of 3∑g-O2.
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increasing [NADH] and concomitant O2.- generation at the FMN site in
complex I [68,69]. Cytochrome c could also use H2O2 to oxidise car-
diolipin, an essential inner membrane phospholipid, to trigger intrinsic
apoptosis [70,71]. Unsurprisingly (1) the brain expends considerable
ATP to maintain intracellular Ca2+ homeostasis and (2) neurodegen-
erative diseases are usually associated with disrupted Ca2+ home-
ostasis.
1.3. Glutamate
Excessive glutamate uptake (e.g. by N-methyl-D-aspartate receptors
(NMDARs)) causes excitotoxicity [72,73] secondary to aberrant Ca2+
signalling—for example, leading to sustained calpain signalling [74].
Glutamate excitotoxicity leads to Ca2+ overload linked mitochondrial
[O2.-/H2O2] release associated cell death, typically via apoptosis and
necrosis [17,75,76]. Ca2+ influx can activate nNOS: opening up the
possibility that NO. inhibits COX to increase mitochondrial [O2.-/H2O2/
ONOO-]. Consistent with pharmacological nNOS blockade protecting
against excitotoxicity [77]. Necrotic cell death amplifies excitotoxicity
by elevating extracellular [glutamate] [78]. Intriguingly, NMDAR
mediated glutamate uptake may be subject to differential spatial reg-
ulation: extra-synaptic uptake causes excitotoxicity whereas synaptic
uptake initiates adaptive responses [79–82]. As Hardingham's group
[79] show synaptic NMDAR mediated glutamergic neurotransmission
up-regulates the peroxiredoxin-thioredoxin (PRDX-TRDX) enzyme
system and down-regulates apoptotic signalling. Perhaps, spatial spe-
cificity underlies generator specific functionality wherein extra-sy-
naptic NMDA linked mitochondrial O2.- generation is neurodegenera-
tive whereas NOX2 linked synaptic NMDA receptor linked O2.- is
protective [83]. Beyond receptors, glutamate can cause excitotoxicity
by inhibiting the system Xc- transporter [84]—which exchanges in-
tracellular glutamate for extracellular cystine [85]. Intracellular cystine
is reduced to cysteine, which can be used by glutamate cysteine ligase
for de novo glutathione (GSH) synthesis [86]. Inhibiting cystine uptake
causes oxidative stress by depleting intracellular [GSH] [84,87]. De-
pleting intracellular [GSH] is sufficient to trigger ferroptosis—iron and
lipid peroxidation dependent cell death [88]—suggesting extracellular
glutamate is an endogenous ferroptotic cue [89,90]. However, as Cao &
Dixon caution [90] despite redox commonalities glutamate ex-
citotoxicity associated cell death and ferroptosis have distinctive ele-
ments, notably the involvement of apoptotic signalling in the former.
1.4. Glucose
The human brain consumes ~25% of circulating [glucose] to sup-
port neuronal activity [91] (corresponding to ~5.6mg glucose per
100 g of brain tissue per min). The fate of glucose in the brain is
complex and involves neuronal-glia metabolic coupling (reviewed in
[3,92]). Glia metabolise glucose to lactate before it is taken up, con-
verted to pyruvate and oxidised by neuronal mitochondria to generate
ATP [3]. Consistent with evidence suggesting neurons efficiently me-
tabolise lactate [93,94]. A related corollary: neurons constitutively
degrade the rate-limiting glycolytic enzyme, phosphofructokinase
(PFK), to preferentially use glucose to power the pentose phosphate
pathway (PPP) [95]. From a redox perspective, transcellular metabolic
coupling seems to compensate for the limited capacity of neurons to
metabolise dicarbonyls owing to low glyoxylase 1 (GLO1) and glyox-
ylase 2 (GLO2) expression [96]. GLO isoforms metabolise methyl-
glyoxyal (MG) [97]—a potentially toxic triose phosphate isomerase
derived dicarbonly [98,99]—in a GSH dependent manner. GLO1
metabolises GSH conjugated MG (i.e. hemithioacetal) to S-D-lactoyl-
glutathione before GLO2 converts S-D-lactoylglutathione to D-lactate
and GSH. Low GLO isoform content coupled to comparatively low
[GSH] sensitises neurons to MG toxicity: 250 µM MG is sufficient to
saturate neuronal MG metabolism whereas astrocytic metabolism re-
mains intact at 2mM [96]. With the caveat that “free” [MG] is typically
2–4 µM [100]. Notwithstanding, MG is reactive—50,000 fold more so
than glucose—and readily forms Shiff bases to glycate proteins, RNA
and DNA [100]. In particular, protein glycation underlies the formation
of advanced end glycation products (AGE), which can cause oxidative
stress by stimulating inflammation via their receptor, impairing protein
and mitochondrial function [100–102]. AGEs can arise in absence of
high glycolytic rates because lipid peroxidation can yield MG [101]. In
sum, the brain is susceptible to glucose induced oxidative stress [97].
1.5. Mitochondria
Disproportionate O2 uptake supports oxidative phosphorylation to
help fuel the brains extraordinary ATP demand [3]. Neurons expend
ATP to maintain ionic gradients and support synaptic activity
[103,104]. The sheer energetic costs of synaptic activity are ex-
emplified by neurotransmitter loaded vesicle release alone consuming
1.64 × 105 ATP per second per vesicle [104,105]. Meeting neuronal
ATP demands requires mitochondria, particularly synaptic mitochon-
dria [106] owing to limited ATP diffusion. Neurons are especially re-
liant on mitochondria because they constitutively degrade PFK to limit
glycolysis [95]—although glycosomes can temporarily support synaptic
ATP synthesis [107]. Beyond oxidative phosphorylation, mitochondria
are essential signalling hubs regulating a veritable plethora of essential
processes, from Ca2+ homeostasis, Fe-S cluster synthesis to cell fate
[55,108,109]. Neuronal mitochondria are a quintessential double-
edged sword: endowing neurons with ATP and signalosomes while
imparting intrinsic neurodegenerative vulnerability to their dysfunction
[110].
Instead of propounding the somewhat prosaic view that O2.-/H2O2
are obligate, toxic by-products of mitochondrial respiration that cause
oxidative damage, we interpret neuronal susceptibility to mitochon-
drial oxidative stress from a signalling perspective [111]. How mi-
tochondria produce O2.-/H2O2 (see Murphy [68] for a comprehensive
review) places them as sentinels of organelle health [112]. Their de-
liberate generation is intimately tied to adaptive redox signalling [113].
Hypoxia signalling is a cogent example. Mitochondria sense hypoxia
(i.e. 0.3–3% O2) by generating complex I and complex III derived O2.-/
H2O2 to activate hypoxia inducible factor one alpha (HIF1-α) via de-
grading propyl hydroxylase. HIF1-α initiates adaptive transcriptional
responses [114–118]. Because mitochondrial O2.-/H2O2 production at a
given site reflects: [O2] [reduced site] and the kinetics of the reaction
[68], hypoxia reduces complex I and III to trigger O2.- generation
(which may be abetted by reduced COX activity to increase local O2
availability). HIF1-α transcribes NDUFA4L2, an alternate complex I
subunit, to suppress O2.- generation to conclude hypoxic signalling
[119]. Aberrant redox signalling can be neurodegenerative. Failing to
terminate mitochondrial O2.- generation could initiate redox regulated
intrinsic apoptosis [120,121]. In addition, misassembled respiratory
chains owing to mito-nuclear mismatch could induce the signal (i.e.
O2.-/H2O2) without the cue (i.e. hypoxia), leading to mal-adaptive re-
sponses [111]. If mutant mitochondria accumulate, they may cause
dysfunction by clonal expanding their number because O2.-/H2O2 reg-
ulate mitochondrial biogenesis [111,122,123].
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1.6. Endogenous neurotransmitter metabolism generates hydrogen peroxide
Endogenous amine based neurotransmitter (e.g. dopamine) meta-
bolism generates mitochondrial H2O2 via monoamine oxidase enzymes.
Monoamine oxidase A (MOA-A) and B (MOA-B) catalyse a deamination
reaction: amine + O2 + H2O→ aldehyde + H2O2 + NH3. While both
enzymes metabolise dopamine, tyramine, tryptamine and noradrena-
line, MOA-A preferentially metabolises 5-hydroxytryptamine whereas
MOA-B prefers 2-phenylethylamine [124,125]. During the catalytic
cycle, amine oxidation to imine reduces a prosthetic flavin moiety,
which reacts with O2 to yield H2O2 [126,127]. Once the flavin is re-
duced, the rate of O2 binding controls H2O2 generation, with the im-
plication that [O2] influences enzyme activity. The affinity of each
isoform for O2 is 10 and 240 µM for MOA-A and MOA-B, respectively
[127]. Under O2 saturated conditions, their capacity to produce H2O2 is
considerable—Cadenas and colleagues [128] showed that tryamine
demaination increases H2O2 levels by approximately 1 nmol/kg−1/
min−1 in brain mitochondria. Axiomatically, the presence of a H2O2
generating enzyme together with neuronal activity induced substrate
flux can cause oxidative stress [17,18]. Particularly, when one con-
siders that MOA-B is localised to the outer face mitochondrial inner
membrane [129] because little endogenous capacity to metabolise
H2O2 in the mitochondrial intramembrane space (MIS) exists. Glu-
tathione peroxidase 4 (GPX4), the sole peroxidase in the MIS [59],
preferentially reduces lipid hydroperoxides (ROOH) over H2O2
[130,131]. MOA-A/B activity can trigger apoptosis in a Ca2+ sensitive
Fig. 2. Mitochondrial redox signalling. A) In normoxia, mi-
tochondrial O2.-/H2O2 release is depicted as being low, based on
the assumption that mitochondria are generating ATP. Electron
flux through CI and CIII is depicted with minimal O2.- generation.
PD uses O2 to hydroxylate HIF1-α before pVHL degrades HIF1-α.
B) In hypoxia, reduced CI and CIII generate O2.-/H2O2. O2.-/H2O2
inactivate PD, possible by liberating active site Fe2+. PD inhibi-
tion enables HIF1-α to enter the nucleus to transcribe hypoxia
associated gene programs. C) Aberrant redox signalling. A mis-
assembled CI owing to mito-nuclear mismatch is depicted (i.e.
grey box over CI). CI mismatch diverts electrons to O2 to generate
O2.-. Various signalling abnormalities may ensue including bio-
genesis, DNA damage responses and apoptosis owing to persistent
mitochondrial O2.- generation are graphically depicted.
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fashion [132–134], which may link MOA/B derived H2O2 and neuronal
cell death. Unsurprisingly, aberrant MOA-A/B activity has been linked
to ageing [135] and related neurodegenerative disorders, notably Alz-
heimer's disease (AD) and Parkinson's disease (PD) [136,137]. Spurring
interest in the use of synthetic MOA-A/B inhibitors to treat neurode-
generation and indeed mood disorders [124,125,138].
An underappreciated aspect of MOA/B biology is by restricting O2.-
induced neurotransmitter oxidation and subsequent redox cycling, they
may limit H2O2 generation. For example, dopamine oxidation can yield
multiple H2O2 molecules [139] whereas stoichiometric MOA-A/B me-
tabolism produces a single H2O2 molecule. With the caveat that certain
aldehydes products (e.g. 4-dihydroxyphenylacetaldehyde) can redox
cycle [140,141]. A related corollary is that by helping to terminate
neuronal activity MOA isoforms may protect against excitotoxicity.
MOA-A/B may also protect the brain from exogenous xenobiotics.
Notwithstanding, electrophilic aldehydes can conjugate macro-
molecules to cause damage [142]. For example, 3,4-dihydrox-
yphenylacetaldehyde, a dopamine metabolite readily conjugates pro-
teins and is toxic to neurons [143]—a rise from 2–3 to 6 µM is sufficient
to cause cell death [144]. MOA isoform activity must, therefore, be
counter-balanced with aldehyde dehydrogenase (ADH) activity to pre-
vent toxicity. Because ADH2 [145] is localised to the mitochondrial
matrix the MIS may be unable to remove aldehydes enzymatically,
which would favour macromolecule conjugates—especially if electrical
charge occludes passive diffusion. Perhaps, electrophilic aldehydes, as
opposed to H2O2, underlie MOA induced oxidative stress. While spec-
ulative, H2O2 signalling may inform the nucleus that aldehydes are
being formed. ADH inhibition contributes to PD [146]—which under-
scores the importance of counter-balancing MOA activity. In sum, MOA
isoforms can cause oxidative stress in the brain.
1.7. Neurotransmitters can auto-oxidise
In their seminal works, Cohen and Heikkla [147,148] showed that
dopamine reacts with O2 to generate a dopamine semiquinone radical,
which can then react with another O2 to generate O2.- and a dopamine
quinone. While the initial rate of semiquinone radical formation is often
slow [19], it can be accelerated by redox active transition metals
[149]—which are abundant in the brain [17]. Dopamine quinones can
combine to yield semiquinones [150]—which react with O2 to give O2.-,
with the caveat that this reaction competes with a cyclisation reaction
that averts redox cycling [151]. The mix of O2.-, H2O2 and .OH detected
is indicative of hydroquinone, semi-quinone and quinone equilibria
[150]. Dopamine oxidation products can also redox cycle [152]. For
example, 6-hydroxydopamine can be reduced to a semiquinone radical
which reacts with O2 to yield O2.-, in turn, O2.- reacts with another 6-
hydroxydopamine to regenerate the semiquinone radical and H2O2. A
situation that leads to further O2.- generation [139] and .OH generation,
provided a fraction of the H2O2 generated reacts with redox active
transition metals [11]. Ubiquitous superoxide dismutase (SOD) iso-
forms [153–155] rapidly remove O2.- (k ~2 × 109 M−1 s−1) to ter-
minate radical chains [156]. The net influence of SOD isoforms is
complex because they can also favour O2.- generation [139,150]. By
restricting [O2.-] to the picomolar range, SOD isoforms can shift equi-
librium reactions of semiquinones towards their reaction with to O2 to
generate O2.-; as is the case for 4-dihydroxyphenylacetaldehyde radical
[140]. Importantly, serotonin and adrenaline also autoxidise, with
adrenalin autoxidation being used to assay SOD activity [157]. Neu-
rotransmitters with catechol groups, therefore, render the brain parti-
cularly sensitive to oxidative stress [17,18]. For example, redox cycling
of dopamine metabolites, in particular 6-hydroxydopamine, contributes
to PD [158,159]. In PD, dopamine oxidation [160] drives mitochon-
drial and lysosomal dysfunction, in part, via dopamine quinones ab-
rogating glucocerebrosidase activity—a lysosomal enzyme implicated
in PD pathogenesis [161]—and elevated mitochondrial [H2O2].
1.8. Modest endogenous antioxidant defence
As reviewed by Halliwell [17,18], modest endogenous antioxidant de-
fence sensitises the brain to oxidative stress. That is, comparatively low en-
dogenous antioxidant defence relative to many tissues (e.g. liver) makes the
brain susceptible to disrupted redox homeostasis. While low catalase con-
tent—neurons possess 50 times lower catalase content compared to hepato-
cytes [162]—is a frequently cited exemplar [163], the relative importance of
catalase to steady-state H2O2 removal is questionable. Aside from catalase
being largely restricted to peroxisomes, its reaction mechanism requires two
H2O2 molecules [164]—which may restrict its activity at nanomolar H2O2
[165]. GSH, however, provides a cogent example. Cytosolic GSH is ~50%
lower in neurons compared with other cells (e.g. ~5mM in neurons com-
pared with 10–11mM in hepatocytes). Low cytosolic GSH reflects, in part, a
reduced capacity for GSH synthesis owing to low γ-GCL content—a corollary
of minimal Nrf-2 content and activity [81,166]. Comparatively, low cytosolic
GSH may restrict GPX4 activity [130], which may explain neuronal sensi-
tivity to ferropotsis [167]. Low GSH may also limit the ability of neurons to
metabolise electrophiles, particularly electrophilic aldehydes. From the dis-
cussion so far, it would seem the apparent defect relates to H2O2 metabolism
[18,19] because SOD isoform content and activity is normative (i.e. no defect
in O2.- metabolism). Intact O2.- metabolism (i.e. SOD activity) is essential
because neurons are unable to survive genetic deletion of MnSOD [168–170],
the mitochondrial isoform [154]. In sum, GSH linked enzymatic systems are
modest in neurons.
In 1994, Soo Goo Rhee's group identified the PRDX family as ubiquitous
cysteine dependent H2O2 peroxidases [171]. PRDX isoforms are reduced by
TRDX, oxidised TRDX is, in turn, reduced by thioredoxin reductase at the
expense of NADPH [172–176]. Their discovery has important implications
for neuronal H2O2 metabolism because neurons express PRDX-TRDX iso-
forms [162,177]. A functional PRRX-TRDX system may enable neurons to
metabolise H2O2—particularly when it is considered that PRDX isoforms
are abundant and distributed throughout the cell [171,175,178]. We are
unaware of any report to the effect that PRDX-TRDX activity is compara-
tively modest in neurons. On the contrary, PRDX activity may be com-
paratively high in neurons as they preferentially funnel glucose into the
NADPH generating PPP [95]. However, enzymes (e.g. NOS) use NADPH to
generate O2.- and NO. [179,180], so it is unwise to assume NADPH ex-
clusively fuels “antioxidants” [181]. However, PRDX6 prefers GSH as a
reductant [182] so comparatively low GSHmay limit its activity. It is remiss
to consider PRDX-TRDX as “only” H2O2 “neutralisers” because compelling
biochemical evidence suggests PRDX-TRDX transduce redox signals
[16,172,183–187]. As Flohé et al. [188] elegantly enunciate nature is un-
likely to have evolved over ten peroxidases just to remove H2O2. Lu,
Holmgren and co-workers [162], suggest that PRDX-TRDX endow neurons
with the capacity to harness their relative “oxidative stress” to transduce
Fig. 3. Neurotransmitter autoxidation. From left to right. A transition metal (Mn+)
catalysed reaction is shown wherein the alpha hydroxyl group of dopamine is oxidised to
the semi-quinone radical. The semi-quinone radical then reacts with O2 to generate O2.-
and a quinone. O2 can re-oxidise the quinone to quinol to generate H2O2. Transition
metals may react with H2O2 to yield indiscriminately reactive .OH.
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redox signals. If so, such a state of affairs is perilous, if PRDX isoforms
become over-oxidised when [H2O2] rises to high nanomolar levels that
seem to herald cell death [45,180]. Particularly, given the modest capacity
of neuronal GSH linked enzyme systems [81,166]. PRDX-TRDX provide a
means to remove, as well as, harness H2O2 for cell signalling but the pos-
sibility remains that beyond a critical threshold elevated [H2O2] easily short
circuits this system to cause oxidative stress.
1.9. Microglia
Microglia are specialised, resident immune cells [189,190] that perpe-
tually scan their local niche for homeostatic threats [191,192]. Microglia
deploy extended processes to survey synapse health by monitoring neuronal
activity [193]. Bymonitoring neuronal activity, microglia play an important
role in removing unhealthy cells, neuronal wiring during development and
activity dependent synaptic plasticity [194–197]. The ground breaking
work of Bernard Babior [198], showed that active immune cells produce
O2.- via NOX isoforms (principally NOX2 [23]). The role of O2.- in bacterial
killing was one of the first examples of a biologically useful role for free
radicals [199]. It is unsurprising, therefore, that microglia generate O2.- and
related reactive progeny during phaogcytoysis [200]. However, one should
note that because O2.- production depends on O2, microglia activity will be
extremely sensitive to local O2 bioavailability—their O2 use may even be
one way to remove synapses by consuming O2 to power O2.-, as opposed to
ATP, synthesis. It is unlikely that facile (e.g. .OH) or anionic species (i.e.
O2.-) exit phagocytic endosomes to harm neighbouring neurons (if anions
did escape their entry is charge restricted in any event), uncharged H2O2
and NO. may diffuse to cause damage or amplify local inflammation by
attracting more microglia. Niethammer's and Amaya's groups have shown
that H2O2 acts as a chemoattractant in wound healing and limb regenera-
tion [201,202]. Patrolling microglia may “sense” H2O2 to induce their ac-
tivation and proliferation [203], which provides a mechanism whereby
neuronal H2O2 release attracts microglia. In support, Lyn, a tyrosine kinase,
detects nerve derived H2O2 and primes microglia for chemotaxis via F-actin
[204]. How Lyn detects H2O2 is unclear but may involve H2O2 linked
phosphatase inactivation [15,16]. Self-amplifying inflammatory loops exist
owing to cytokine and peroxidised lipid induced microglia activity
[205,206]. While essential for normal brain development and function,
unabated microglia activity can cause oxidative stress [206]. For example,
in AD, microglia prune synapses to drive neurodegeneration [207,208].
Whether aberrant pruning requires oxidative stress is unclear., Perhaps
peroxidised lipid metabolies [209](e.g. 4-HNE) attract microglia by mod-
ifying protein cysteine residues via Michael addition [210,211].
1.10. Redox active transition metals
Redox active transition metals (i.e. Fe2+ and Cu+) are enriched in the
brain [17,18]. The relative abundance of transition metals in the brain is
underlined by their 10,000 enrichment relative to neurotransmitters
[212,213]. Chelated [Fe2+] alone can reach mM levels. Nature harnesses
the rich biochemistry of Fe2+ and Cu+ to accelerate chemical reactions. For
example, Fe2+ can bind electron dense O and N groups in organic mole-
cules [214]. Accordingly, Fe2+ (and Fe3+) is required to ensure the cata-
lytic activity of several enzymes, including aconitase, fumarase and cyto-
chrome P450 [214]. In addition, Fe2+ is essential for myelin synthesis
[215,216] acting as a co-factor for essential de novo lipid synthesis enzymes.
Neurons also harbour a loosely chelated Fe pool, termed the labile iron pool
(LIP), which depending on dietary Fe intake is ≈20 µM in most tissues
[167,217]. Fe enrichment means neurons must tightly control [O2.-/H2O2]
to avoid the perils of mis-metallation—a corollary of FeS displacement
[218]—and Fenton chemistry, which yields indiscriminately reactive .OH
(Fe2+ + H2O2 → OH- + .OH) [19]. Even with abundant and kinetically
rapid SOD enzymes maintaining steady-state [O2.-] in the picomolar range,
Imlay [219] estimates the half-time for mononuclear enzyme damage is still
~20min owing to favourable kinetics (k ~106 M−1 s−1). For example,
Fe2+ loss inactivates the PPP enzyme ribulose-5-phosphate 3-epimerase
[220]. Such inactivation may only be transient as compensatory mechan-
isms exist (e.g. Mg2+ insertion, or LIP mediated re-metallation [220]).
Notwithstanding, ablated PPP activity owing to ribulose-5-phosphate 3-
epimerase inactivity could compromise neuronal function by restricting
nucleotide synthesis [221]. Of particular interest, Fe2+ regulates ferropo-
tosis—a novel Fe2+ and lipid peroxidation dependent form of cell death
[88,167]. Fe2+ contributes to ferroptosis by catalysing peroxyl (ROO.) and
aloxyl (RO.) radical generation from ROOH in a reaction is kinetically fa-
voured (k ~1.3 × 103 M−1 s−1) compared to Fenton reaction(k ~76M−1
s−1) [19,222,223]. The influence of Fe2+ is complex because Fe2+ can
inhibit lipid peroxidation by scavenging ROO. and RO. in kinetically faster
reactions [222] (e.g. RO. + H+ + Fe2+ → ROH + Fe3+, k ~3.0 × 108
M−1 s−1). However, low [ROO./RO.] means Fe2+ is more likely to react
with ROOH. For these reasons, the brain is susceptible to dysregulated Fe
homeostasis [224]. The pathological susceptibility of the brain to dysre-
gulated Fe2+ homeostasis is underscored by the observation that iron-
amyloid beta complexes contribute to plaque deposits in AD [225].
Analogous to Fe2+, neurons contain a “labile” Cu+ pool [226] that
seems to be important for cell signalling and neuronal excitability
[227,228]. For example, neuronal activity redistributes the loosely chelated
Cu+ pool from the soma to dendrites, which regulates spontaneous neu-
ronal activity [227,229,230]. In addition, Cu+ is an essential co-factor for
enzymes [212], prominent examples being COX and copper zinc SOD
(CuZnSOD) [153,231,232]. Neuronal Cu+ enrichment (0.1mM, up to
1.3mM in certain regions) predisposes to Cu2+ catalysed Fenton chemistry
and H2O2 assisted protein oxidation [212]. The potential perils of dysre-
gulated Cu+ homeostasis are exemplified in ALS. Specifically, mutated
CuZnSOD variants contribute to both familial and sporadic ALS [233]. How
CuZnSOD causes neurodegeneration is incompletely understood [234,235]
but may relate to a toxic gain of function involving protein aggregates,
peroxidase activity, which can generate CO3.- generation via HOOCO2
[231,236], and thiol oxidase activity [237,238]. In addition, reduced
CuZnSOD activity can also increase [ONOO-] [239].
1.11. Unsaturated lipid enrichment
The brain is the major sink for polyunsaturated n-3 fatty acids [240],
notably DHA. Given their ATP demands, one would expect neurons to
oxidise lipids to generate ATP, particularly since the ATP yield is greater:
106 ATP per mol palmitic acid vs 32 ATP per mol glucose [241], and only
14–17 ATP per mol lactate [3]. However, compared with other metaboli-
cally active tissues (e.g. skeletal muscle [242]), beta oxidation is limited in
the brain [241]. Perhaps, to conserve O2—oxidising palmitc acid consumes
15% more O2—and, in light of modest catalase activity [163], to limit
preoxisomal enzyme induced H2O2 generation [243,244]. Recalcitrance to
oxidising lipids to generate ATP may stem from using peroxidised lipids to
signal [19]. For example, DHA can be metabolised to anti-inflammatory
resolvins [245]. Beyond DHA, myelin synthesis requires fatty acids being
enriched with cholesterol—its importance being reflected by the brain ac-
counting for ~20% of total cholesterol [19]. Cholesterol auto-oxidises by
free radical and non-radical mechanisms [246]. High unsaturated lipid
content defines a cause of oxidative stress because of their susceptibility to
lipid peroxidation and indeed may be the biological cost of using perox-
idised lipids to signal [89].
Lipid peroxidation (reviewed in [43,247–250]) involves the initial
generation of a carbon radical following an addition or abstraction
reaction by a sufficiently reactive species (e.g. .OH) on a methylene
group. As an aside, .OH may be dispensable for initiating lipid perox-
idation, hyper-valent Fe-O species (e.g. FeIV=O) may be key [222].
Carbon radicals rapidly react with O2 to yield ROO., which can abstract
a bis-allyic H+ from another methleyne group to propagate the radical
chain by yielding ROOH and a carbon radical [43,247–250]. Alpha
tocopherol (α-TOC) terminates radical chain propagation to yield
ROOH and a resonance stabilised α-TOC radical [249]. ROOH can react
with redox active transition metals to re-generate ROO. and RO. [222].
GPX4 rapidly removes ROOH to yield ROH [251], before the inactive
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enzyme is regenerated using GSH, which is, in turn, regenerated using
NADPH dependent glutathione reductase [130,131,188]. Ferroptosis
[90,252] explains why genetically deleting GPX4 is embryonically le-
thal [253,254] because GPX4 regulates ferroptosis by removing ROOH
[223,255]—gain and loss of GPX activity is sufficient to disable and
activate ferroptosis [256], respectively. Modest [GSH] may render
neurons particularly susceptible to ferropotsis confirmed by the ob-
servation that conditionally deleting GPX4 is lethal to neurons
[257–259]. Consistent with lipid peroxidation contributing to the pa-
thogenesis of neurodegenerative diseases (e.g. AD [209,211]).
1.12. The brain uses NOS and NOX for signalling
The brain harnesses nNOS and NOX isoforms to achieve essential
functions. First, nNOS uses O2, NADPH and L-arginine to catalytically
synthesise NO. [37]. The affinity of nNOS for O2 is 300 µM, mean brain
[O2] is ~20 µM, which may limit NO. synthesis [260]. NO. regulates
essential physiological processes, including LTP [261,262], axon
growth [263] and pruning [264]. As discussed, NO. can underlie oxi-
dative stress—especially when O2.- is co-generated. nNOS biochemistry
means that O2.- and NO. can be spatially co-generated making [ONOO-]
generation likely [265]. Co-fluxes occur when nNOS is uncoupled.
Uncoupling typically arises when essential co-factors (e.g. tetra-
hydrobiopterin) become oxidised or unbound. Second, NOX isoforms
use prosthetic redox groups to oxidise NADPH to reduce O2 to O2.-
[22,23]. NOX isoforms are important in the brain (reviewed in [266])
to support microglia and LTP to give just two examples [24]. Because
NOX isoform mediated O2.- generation is far from adventitious being
regulated at several levels [22,23,267], NOX isoform associated oxi-
dative stress likely stems from the unwanted and continued presence of
activating cues coupled to a sustained supply of NADPH and O2 to
support enzyme activity. Such a scenario may manifest in neuronal
inflammation [206] wherein cytokines provoke and sustain microglia
NOX2 associated O2.- generation [205].
1.13. RNA oxidation
RNA oxidation is a seldom appreciated reason why the brain is
susceptible to oxidative stress [268]. Beyond essential messenger RNA,
the brain heavily relies on non-coding RNAs, particularly long non-
coding RNAs and microRNAs (reviewed in [269–271]). From a bio-
chemical perspective, RNA is equally susceptible to oxidation as DNA,
undergoing analogous reactions [272]. For example, 8-oxo-guanine is a
principal outcome of both DNA and RNA oxidation [273]. Owing to its
single-stranded nature, RNA is also vulnerable to oxidation and indeed
alkylation [274] at Watson-Crick interfaces. RNA also lacks protective
histones and nuclear compartment in axons and synapses. Although
local protein synthesis is essential to synaptic function [275,276], the
possibility that RNA oxidation perturbs local protein synthesis is un-
explored. Oxidised RNA associated coding errors stall ribosomal protein
synthesis [277], which can if left unrepaired produce truncated, mu-
tated and mis-folded proteins [278]. The spatial positioning of mRNA
close to mitochondria and the temporal dynamics of RNA oxidation
(order of seconds) compared with translation (order of hours) make
RNA oxidation likely—especially in neurons with divalent redox active
transition metals present to catalyse Fenton chemistry [279–281]. The
mandate to consider mRNA oxidation as a cause of oxidative stress
associated neurodegeneration is strengthened by the observation that
oxidised CuZnSOD mRNA is an early pre-clinical feature of ALS [282].
As a number of excellent reviews [268,272] surmise further work is
required to understand oxidised RNA recognition, turnover and repair
[283]. Only with a better understanding of each process can one ap-
praise the neuronal susceptibility to RNA oxidation because [oxidised
RNA] is a function of formation and removal over time.
2. Perspectives
We wish to propose an overarching perspective for interpreting why
redox signalling leads to oxidative stress in the brain. The ultimate price
of using redox signalling to inform brain function is innate suscept-
ibility to oxidative stress when signals go awry—as seems to be the case
in disease. Few neuroscientists would deny the central importance of
neuronal activity. Based on how mitochondria produce O2.-/H2O2 [68],
neuronal activity should divergently regulate mitochondrial O2.-/H2O2
generation. At an active synapse, ATP demands—provided they can be
met—should reduce net mitochondrial O2.-/H2O2 generation. Whereas
at an inactive synapse, low ATP demands and a reduced respiratory
chain should favour mitochondrial O2.-/H2O2 generation, potentially
placing mitochondrial O2.-/H2O2 as synaptic activity sentinels. If so, one
can rationalise how synaptic inactivity induced mitochondrial O2.-/
H2O2 release triggers long-term depotentation (LTD) and even synapse
pruning—especially if the same pathway is used reiteratively [284].
Mitochondrial apoptosis regulates LTD and pruning [285–287]. Mi-
tochondrial inactivity associated O2.-/H2O2 release may induce local
sub-lethal intrinsic apoptosis to induct LTD and pruning. Perhaps, redox
regulated apoptosis enables the developing brain to prune
Fig. 4. Lipid peroxidation. (1) Initiation..OH abstracts a H+ from
an unsaturated lipid to yield a carbon radical. (2) Oxygenation. O2
reacts with the carbon radical to yield ROO. (3) Propagation.
ROO. abstracts a H+ from an unsaturated lipid to yield ROOH and
a carbon radical. (4). Termination. Alpha tocopherol (VE) termi-
nates chain radicals by reacting with ROO. to yield ROOH. (5).
GPX4. GPX4 converts ROOH to the corresponding alcohol. GPX4
is regenerated by 2GSH and the resultant GSSG is reduced by GR
using PPP derived NADPH. 6. Fe2+. Fe2+ reacts with ROOH to
yield ROO.. ROO. can initiate lipid peroxidation, which triggers
ferroptosis when GPX4 activity is suppressed. In addition, Fe2+
can convert H2O2 to .OH (i.e. Fenton chemistry) to initiate lipid
peroxidation. Ferritin can limit lipid peroxidation by ligating
Fe2+. Certain steps (e.g. carbon radical re-arrangement) are
omitted for clarity.
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synapses—the essential prelude to a complex connectome and manda-
tory requirement for continued sculpting in adulthood [284]. Placing
mitochondria with their hands on the proverbial shears renders the
brain vulnerable to unwanted synapse loss. If mitochondria are unable
to meet ATP demands or if O2 is limiting resultant O2.-/H2O2 release
may recapitulate the “pruning” signal to cause unwanted synapse loss.
Biological precedent exists: unwanted reactivation of developmental
pruning signalling contributes to synapse loss in AD [207].
In biochemically rationalising 13 reasons why the brain is suscep-
tible to oxidative stress, we deliberately adopted a global view focusing
on “neurons” as a collective for the purposes of a general primer. Apt
parallels between the monolithic umbrella terms neurons and reactive
species exist [20]. Reactive species subsumes chemically heterogeneous
species, that can differ in their rate of reaction with a given substance
by orders of magnitude (e.g. for guanine .OH reacts at a diffusion
controlled rate whereas O2.- leaves guanine unscathed owing to low
reactivity). Analogous to reactive species, neurons are heterogeneous
being ill-served by global monikers because they can widely differ in
many key parameters, including function, location, connectivity, mye-
lination and axon length. Neuronal heterogeneity informs differential
susceptibility to oxidative stress both within a neuron (i.e. soma vs.
synapse), subdomain (i.e. synaptic mitochondria vs. synaptic mem-
branes) and between neuronal populations. Dopaminergic neurons in
the substantia nigra pars compacta exemplify differential vulnerability:
they experience residual (i.e. without additional homeostatic pertur-
bation) oxidative stress because an L-type Ca2+ channel defined mi-
tochondrial O2.-/H2O2 axis controls their autonomous pace-making
capacity [288]. Teetering on the edge of an oxidative breakpoint, even
minor unchecked shifts in the intracellular redox en-
vironment—perhaps related to dopamine metabolism [160]—seem
sufficient to herald their demise.
Neuronal sensitivity to oxidative stress oscillates. Just as steady
state [O2.-] reflects its dynamic rate of generation and removal in a given
compartment [68], a myriad of interconnected factors dynamically set
neuronal sensitivity to oxidative stress over time. We briefly consider
Fe2+ mediated ROOH reduction to ROO. as a topical example relevant
to ferroptosis [223]. The second order bimolecular elementary reaction
is informed by the rate constant, [ROOH]ss and [Fe2+]ss. Reactant
availability at a given time governs the probability of ROO. gen-
eration—with GPX4 catalysed ROOH metabolism and ferritin mediated
Fe2+ chelation being prominent examples. If a xenobiotic conjugates
GSH [19] to abrogate local [GSH] to compromise GPX4 activity, ROO.
generation may be favoured. That the “history” of the neuron influences
susceptibility to a redox challenge adds complexity. For example, sy-
naptic activity associated sub-lethal redox challenges herald co-ordi-
nated transcellular neuronal-glia adaptive responses that increase
neuronal [GSH] (reviewed in [81]). In our example, an adapted neuron
is better able to buffer the xenobiotic mediated GSH conjugation to
abrogate ROO. generation to thereby raise the peroxidised lipid load
required for ferroptosis [89]. As a cautionary note, adaption requires
frequent stimulus because [GSH] is transcription dependent at multiple
levels. An intriguing parallel with the exercise physiology axiom “use it
or lose it” emerges: activity dependent beneficial adaptive redox re-
sponses persist with continued activity but progressively decay with
inactivity.
From a translational perspective, the sheer complexity of neuronal
redox homeostasis helps rationalise the failure of nutritional antioxidants to
treat neurodegenerative diseases [289]. Bioavailability concerns aside,
their failure relates to kinetic and spatial constraints (reviewed in
[181,290–293]). The probability of any one compound possessing sufficient
biochemical versatility to significantly modify each reason simultaneously is
low. Above all, the failure of nutritional antioxidants reinforces their in-
herent biochemical strictures—being insufficient evidence to dismiss a
causative role for oxidative stress. Much brain redox homeostasis in health
and disease remains opaque. Only when basic research unmasks the
mechanistic details can one rationally design redox active therapeutics for
neurodegenerative diseases.
3. Conclusion
A complex interconnected myriad of reasons render the brain sus-
ceptible to oxidative stress; just 13 (many more exist [17,18]) reasons
include unsaturated lipid enrichment, glucose, mitochondria, calcium,
glutamate, modest antioxidant defence, redox active transition metals,
neurotransmitter auto-oxidation and RNA oxidation. The brain is sus-
ceptible to oxidative stress because it harness chemically diverse re-
active species to perform heterogeneous signalling functions. From
using lipid radicals to trigger ferroptosis when lipid signalling fails, NO.
to fine-tune synaptic plasticity or mitochondrial O2.-/H2O2 to signal
hypoxia. The balance between species specific useful and harmful
biochemistry is a fine one, which, in the brain, means the relationship is
bittersweet: exquisite redox signalling functionality easily gives rise to
oxidative stress when electrons go awry.
Fig. 5. Use it or lose it. (1) Depicts GSH-linked GPX4 ROOH metabolism in an adapted
(left) and non-adapted neuron (right). Neuronal activity induced GSH up-regulation
supports GPX4 activity to decrease [ROOH] to avert Fe2+ catalysed radical reactions,
which re-initiate lipid peroxidation. In the non-adapted neuron, low [GSH] increases the
likelihood of Fe2+ reacting with ROOH owing to decreased GPX4 activity. (2) A theo-
retical threshold model wherein the adaptive history (described above) divergently
modulates the peroxidised lipid load required to induct ferroptosis. An adapted neuron,
can withstand a larger absolute rise in [ROOH] before undergoing ferroptosis. (3) A
theoretical threshold model an adapted neuron loses its ferroptotic resistance with per-
sistent inactivity. Hence, a lack of stimulus (e.g. neuronal activity) erodes the adaptation.
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